- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Dr. David H Ilson
Dr. David H. Ilson is a medical oncologist and an attending physician at Memorial Sloan-Kettering Hospital in New York City. He attained a Master’s Degree and a Ph.D. in basic science, and received his medical degree from New York University. His internship and residency in internal medicine were completed at Bellevue Hospital, part of the NYU Medical Center. His fellowships in medical oncology and hematology were both completed at Memorial Sloan-Kettering Cancer Center. Dr. Ilson also teaches medicine at Weill Medical College at Cornell University.
Dr. Ilson’s expertise includes the treatment of malignant mesothelioma, and he is a leader in research in the field. In addition to mesothelioma, Dr. Ilson’s interests include cancers of the gastrointestinal tract such as colon cancer, cancer of the esophagus, pancreatic cancer, and gastric cancer. He also studies and treats unknown primary tumors in patients. He conducts research in the area of new drugs to treat more advanced diseases and evaluates the effectiveness of these new drugs in combined-modality treatments in diseases that are more advanced. This includes exploring different approaches to tumor treatment that combine surgery, chemotherapy, and radiation as one treatment strategy.
For his work with mesothelioma patients, Dr. Ilson has the support of an experienced team of healthcare professionals including medical oncologists, radiation oncologists, pathologists, and scientists at Memorial Sloan-Kettering. The hospital and Dr. Ilson treat mesothelioma patients with cutting-age therapies through the use of clinical trials.
Among the mesothelioma therapies applied by Dr. Ilson and the staff at Memorial Sloan-Kettering is the removal of the affected lung and its lining, along with the diaphragm on the side of the body that is affected. This surgery has been proven effective through numerous clinical trials.
Dr. Ilson and the staff also apply innovative radiation therapy like intensity-modulated radiation therapy (IMRT). This type of treatment targets the radiation directly to the pleura of the lung. Clinical trials are being conducted to ensure that this treatment is safe and effective.
Dr. Ilson’s staff is conducting a Phase III clinical study to test a new chemotherapy drug made particularly for patients who have already received chemotherapy treatment with other agents.
Dr. Ilson belongs to the GI committees that are part of the national clinical research groups for Cancer and as well as for Leukemia. He is also a member of the Radiation Therapy Oncology Group and the Upper GI Cancer Guidelines Committee of the National Comprehensive Cancer Network.